Neoadjuvant rh-endostatin, docetaxel and epirubicin for breast cancer: efficacy and safety in a prospective, randomized, phase II study.

Neoadjuvant rh-endostatin, docetaxel and epirubicin for breast cancer: efficacy and safety in a prospective, randomized, phase II study.

Item
http://www.wikidata.org/entity/Q34732915
Recent advances in the pathobiology and management of Kasabach-Merritt phenomenon.Recombined humanized endostatin (Endostar) combined with chemotherapy for advanced bone and soft tissue sarcomas in stage IV.Soy and breast cancer: focus on angiogenesis.Endostatin's emerging roles in angiogenesis, lymphangiogenesis, disease, and clinical applications.Efficacy and safety of extended use of platinum-based doublet chemotherapy plus endostatin in patients with advanced nonsmall cell lung cancerThe efficacy and safety of endostar combined with taxane-based regimens for HER-2-negative metastatic breast cancer patients.The Angiogenic Secretome in VEGF overexpressing Breast Cancer Xenografts.Usefulness of dynamic contrast-enhanced magnetic resonance imaging for predicting treatment response to vinorelbine-cisplatin with or without recombinant human endostatin in bone metastasis of non-small cell lung cancer.Combining antiangiogenic therapy with neoadjuvant chemotherapy increases treatment efficacy in stage IIIA (N2) non-small cell lung cancer without increasing adverse effects.Matricryptins and matrikines: biologically active fragments of the extracellular matrix.Recombinant human endostatin in combination with CHOP regimen for peripheral T cell lymphoma.Antiangiogenic Therapy for Diabetic Nephropathy.A randomized Phase III trial of neoadjuvant recombinant human endostatin, docetaxel and epirubicin as first-line therapy for patients with breast cancer (CBCRT01).Endostar combined with chemotherapy in a pediatric osteosarcoma with pulmonary metastasis and malignant pleural effusion: A case report.Effectiveness of Treatment with Endostatin in Combination with Emcitabine, Carboplatin, and Gemcitabine in Patients with Advanced Non-small Cell Lung Cancer: A Retrospective Study.
P2860

Neoadjuvant rh-endostatin, docetaxel and epirubicin for breast cancer: efficacy and safety in a prospective, randomized, phase II study.

Item
http://www.wikidata.org/entity/Q34732915
description
2013 nî lūn-bûn
@nan
2013 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Neoadjuvant rh-endostatin, doc ...... e, randomized, phase II study.
@ast
Neoadjuvant rh-endostatin, doc ...... e, randomized, phase II study.
@en
Neoadjuvant rh-endostatin, doc ...... e, randomized, phase II study.
@nl
type
label
Neoadjuvant rh-endostatin, doc ...... e, randomized, phase II study.
@ast
Neoadjuvant rh-endostatin, doc ...... e, randomized, phase II study.
@en
Neoadjuvant rh-endostatin, doc ...... e, randomized, phase II study.
@nl
prefLabel
Neoadjuvant rh-endostatin, doc ...... e, randomized, phase II study.
@ast
Neoadjuvant rh-endostatin, doc ...... e, randomized, phase II study.
@en
Neoadjuvant rh-endostatin, doc ...... e, randomized, phase II study.
@nl
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P407
P478
P577
P5875
P6179
P698
P932
P356
P1433
P1476
Neoadjuvant rh-endostatin, doc ...... e, randomized, phase II study.
@en
P2093
P2860
P2888
P304
P31
P356
P407
P478
P577
P5875
P6179
P698
P932